Bioalpha Holdings Bhd (XKLS:0179) Total Equity: RM65.37 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Bioalpha Holdings Bhd Total Equity?

Bioalpha Holdings Bhd XKLS:0179 Total Equity is RM65.37 Mil as of Mar. 2026. The stock has 6 warning signs investors should review.

Bioalpha Holdings Bhd's total equity for the quarter that ended in Mar. 2026 was RM65.37 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Bioalpha Holdings Bhd Total Equity Historical Data

* Premium members only.

The historical data trend for Bioalpha Holdings Bhd's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioalpha Holdings Bhd Total Equity Chart

Bioalpha Holdings Bhd Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 186.34 167.99 129.63 97.72 68.39

Bioalpha Holdings Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 90.88 81.36 76.91 68.39 65.37

Bioalpha Holdings Bhd Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Bioalpha Holdings Bhd's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=79.147-10.755
=68.39

Bioalpha Holdings Bhd's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=75.296-9.924
=65.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of RM65.37 Mil mean?
Bioalpha Holdings Bhd (XKLS:0179) has a Total Equity of RM65.37 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Bioalpha Holdings Bhd and its competitors.
Is Bioalpha Holdings Bhd's Total Equity too high?
Bioalpha Holdings Bhd's current Total Equity is RM65.37 Mil.
How does Bioalpha Holdings Bhd's Total Equity compare to KHC and GIS?
Bioalpha Holdings Bhd's Total Equity of RM65.37 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Consumer Packaged Goods company?
A good Total Equity depends on the Consumer Packaged Goods industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Bioalpha Holdings Bhd and its competitors. Bioalpha Holdings Bhd's current Total Equity is RM65.37 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioalpha Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Bioalpha Holdings Bhd (XKLS:0179) is currently considered Significantly Overvalued. The stock's GF Value™ is RM0.01, compared to a current price of RM0.02 — trading 100% above its estimated fair value. The current Total Equity is RM65.37 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Bioalpha Holdings Bhd (XKLS:0179), the current Total Equity is RM65.37 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioalpha Holdings Bhd Business Description

Address No. 1, Jalan Perindustrian Suntrack, Hub Perindustrian Suntrack, Bandar Baru Bangi, Off Jalan P1A, Seksyen 13, Kajang, SGR, MYS, 43000
Bioalpha Holdings Bhd is a nutraceutical and health supplement group in Malaysia, operates a multi-faceted value chain that includes agricultural development, research and development (R&D), and the manufacturing of functional food and supplement products on an Original Design Manufacturer (ODM) basis. The business operates in segments that include Trading, Manufacturing, Retail pharmacy, and Others. It generates maximum revenue from Manufacturing segment, which involves Research, development, manufacture, importer, exporter, distribution and trader of nutritional and health care products. Geographically, the company derives majority revenue from Malaysia, while it also has its presence in China and Others.